Menu
Packaging Industry Reports
  • About Us
  • Contact Us
  • Home
  • Our Team
  • Privacy Policy
Packaging Industry Reports
Alzheimer's Disease Drug

Parasitic Chagas Disease Can Be Treated With Alzheimer’s Disease Drug

Posted on September 30, 2019September 30, 2019

Allegedly, the drugs that are currently used in the treatment of Chagas disease—which is an infectious disease caused by the parasite Trypansosoma cruzi—have severe side effects and restricted use in those having a chronic disease. The scientists have stated that memantine—a drug presently used to cure Alzheimer’s disease—can reduce variety of parasites in mice with Chagas disease and augment the odds of survival in the animals. Reportedly, Chagas disease affects 5–6 Million people across the U.S. The disease can be categorized into chronic and acute phases, with the clinical stage leading to esophagus, heart, or intestinal symptoms. The research was published in the journal PLOS Neglected Tropical Diseases.

Two drugs have been used to cure Chagas for the past 50 Years—benznidazole and nifurtimox—are highly efficient in the acute phase but are utilized cautiously in the chronic phase owing to severe side effects that takes place with long-term treatment. Ariel M. Silber—from Universidade de São Paulo, Brazil—along with colleagues analyzed memantine that functions on the central nervous system of animals and also is known to kill protozoa. The scientists first analyzed the impact of various concentrations of memantine on cultivated macrophages—which is a type of WBC (white blood cell)—that were infected with T. cruzi. The team discovered that memantine decreased the variety of T. cruzi-diseased macrophages in a dose-reliant method and more drugs caused to a higher lessening in the infection.

On a similar note, recently, researchers identified how the exosomes of the parasite are responsible for Chagas disease that affects heart cells. This is a serious parasitic disease that impacts over 8 Million people across the globe and for which there is presently no treatment. A team of researchers from the UGR (University of Granada) has successfully identified the mechanism in which exosomes (extracellular nanovesicles) discharged by the parasite are liable for the disease attack heart cells, therefore causing one of its most common complications, cardiac disease.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Business
  • Health
  • Science
  • Technology
  • Top Stories
  • Clean Label Flavors Market Insights 2022-2030
  • P&G Fabric & Home Care is testing Lenor in paper bottles with Paboco
  • Abel & Cole uses compostable plastics in all of their fruit and vegetable cartons
  • Global Silicone Surfactants Market Size, Shares, Trends, Growth, Forecast 2028
  • Manchester-based packaging maker Duo invested £3m in a Leeds recycling business
©2023 Packaging Industry Reports | Powered by SuperbThemes & WordPress